CDK8 has been outlined as a proto-oncogene, with multiple studies correlating elevated CDK8 expression to poor clinical prognosis in various solid malignant tumors [34], including ovarian cancer [35]. This evidence concerns the gene CDK8 and ovarian carcinoma.